Boston Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Boston Advisors’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-99,509	Closed	-$5.25M	–	662
2017 Q2	$5.25M	Buy	99,509 +26,401	+36%	+$1.41M	0.12%	208
2017 Q1	$4.06M	Sell	73,108 -2,680	-4%	-$148K	0.1%	240
2016 Q4	$3.95M	Sell	75,788 -26,399	-26%	-$1.27M	0.09%	244
2016 Q3	$4.93M	Sell	102,187 -34,001	-25%	-$1.72M	0.12%	202
2016 Q2	$7.54M	Sell	136,188 -16,644	-11%	-$917K	0.19%	147
2016 Q1	$8.16M	Buy	152,832 +17,385	+13%	+$856K	0.2%	132
2015 Q4	$6.97M	Buy	135,447 +107,560	+386%	+$5.34M	0.16%	174
2015 Q3	$1.26M	Buy	27,887 +3,238	+13%	+$153K	0.05%	341
2015 Q2	$1.14M	Buy	24,649 +6,760	+38%	+$296K	0.05%	277
2015 Q1	$767K	Buy	+17,889	New	+$682K	0.03%	340

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MRCP

Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Advisors's PBH Position: Q3 2017 in Review

Boston Advisors sold out of Prestige Consumer Healthcare (PBH) in Q3 2017, closing a stake of 99,509 shares — an estimated $5.25M sold.

Boston Advisors first reported a position in PBH in Q1 2015 and held it in 10 quarters. The position peaked at $8.16M in Q1 2016. 239 funds tracked by Wall St. Rank hold PBH as of Q3 2017.

Boston Advisors reported no remaining Prestige Consumer Healthcare position as of Q3 2017 after selling out during the quarter.
Boston Advisors sold 99,509 Prestige Consumer Healthcare shares in Q3 2017, an estimated $5.25M.
Boston Advisors first reported a position in Prestige Consumer Healthcare in Q1 2015 and held it in 10 quarters.
Boston Advisors's Prestige Consumer Healthcare position peaked at $8.16M in Q1 2016.
239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2017.

Based on Boston Advisors's 13F filing for Q3 2017, filed 24 Oct 2017.